Contact Us
Subscribe
e-Edition

Dashboard
Logout

- My Account
- Dashboard
- Profile
- Saved items
- Logout

Facebook

51°
- Mammoth Lakes, CA (93546)
  Today
  
  Sunny to partly cloudy. Near record high temperatures. High 61F. Winds SSW at 5 to 10 mph..
  
  Tonight
  
  Some clouds. Low 39F. Winds WSW at 10 to 15 mph.
  
  Updated: December 16, 2025 @ 11:19 am
- Full Forecast

Site search

Home
News
Sports/Outdoors
Events
- Archives
Obituaries
Classifieds
- Place an ad
E-Edition
Special Sections
- Eastern Sierra Fishing Guide
- 2024 Summer Olympics

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Allogene Therapeutics, Inc. - Common Stock (NQ:ALLO)

1.522 +0.052 (+3.56%)

Streaming Delayed Price Updated: 2:53 PM EST, Dec 16, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Allogene Therapeutics, Inc. - Common Stock

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Being First Is Not Enough For Crispr Therapeutics ↗

November 15, 2021

CRSP stock is facing competition and meeting skepticism as the company tries to turn CRISPR-CAS9 into profitable drug therapies.

Via InvestorPlace

Allogene Therapeutics Inc (ALLO) Q3 2021 Earnings Call Transcript ↗

November 05, 2021

ALLO earnings call for the period ending September 30, 2021.

Via The Motley Fool

Topics Earnings

The Daily Biotech Pulse: Merck's Oral COVID-19 Pill Authorized In UK, Novartis Cashes Out Of Roche, Chimerix Plunges On Data, Evotec IPO ↗

November 04, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck's Oral Antiviral COVID-19 Pill Authorized In UK Merck &...

Via Benzinga

The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline ↗

October 31, 2021

Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly better than expected. Merck & Co, Inc...

Via Benzinga

The Alliance for Regenerative Medicine Announces Election of 2022 Officers, Executive Committee, and Board of Directors

October 21, 2021

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

2 Top Healthcare Stocks That Could Be Bought Out in 2022 ↗

October 16, 2021

These two novel-drug makers could be top takeover targets next year.

Via The Motley Fool

Market Rally Takes Hold As Leading Stocks Shine; Tesla, Taiwan Semi, Delta In Focus: Weekly Review ↗

October 15, 2021

It's a confirmed rally again, with the major indexes rebounding on strong earnings and falling yields.

Via Investor's Business Daily

Why Shares of Allogene Therapeutics, Beam Therapeutics, Intellia Therapeutics, and Schrödinger Are Volatile This Week ↗

October 15, 2021

A key gene-editing readout had Cathie Wood shuffling her portfolio.

Via The Motley Fool

Accelerating R&D Activities in Breast Cancer Therapy Market Fueling Optimism for Development of Advanced Treatments

October 14, 2021

Palm Beach, FL – October 14, 2021 – FinancialNewsMedia.com News Commentary – The breast cancer drugs market, which has been steadily growing over the past few years, is projected to continue this trend...

Via FinancialNewsMedia

50 Biggest Movers From Yesterday ↗

October 14, 2021

Gainers Jasper Therapeutics, Inc. (NASDAQ: JSPR) shares surged 105.1% to close at $14.79 on Wednesday after Oppenheimer initiated coverage on the stock with an Outperform rating...

Via Benzinga

Will Crispr Stock — And Its Cancer Drug — Rise After Allogene's Massive Fall? ↗

October 12, 2021

Crispr is planning to begin a registrational test in the first quarter of 2022.

Via Investor's Business Daily

What 5 Analyst Ratings Have To Say About Allogene Therapeutics ↗

October 12, 2021

Within the last quarter, Allogene Therapeutics (NASDAQ:ALLO) has observed ...

Via Benzinga

The Daily Biotech Pulse: NRx Stitches COVID-19 Drug Partnership, Protara Gets Nod For Starting Bladder Cancer Study, IGM Moves Beyond Oncology ↗

October 12, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 11) AstraZeneca Plc (NASDAQ:...

Via Benzinga

35 Biggest Movers From Friday ↗

October 11, 2021

Gainers ChemoCentryx, Inc. (NASDAQ: CCXI) shares surged 96% to close at $38.41 on Friday. The FDA approved ChemoCentryx’s Tavneos (avacopan) as an adjunctive treatment for...

Via Benzinga

The Week Ahead In Biotech (Oct. 10-16): Avadel FDA Decision, Conference Presentations And IPOs Take Center Stage ↗

October 10, 2021

Biotech stocks retreated in the week ending Oct. 8, extending losses for the third straight week. Some of the selling in the space was due to money moving out of defensive stocks and into risky bets...

Via Talk Markets

The Week Ahead In Biotech (Oct. 10-16): Avadel FDA Decision, Conference Presentations And IPOs Take Center Stage ↗

October 10, 2021

Biotech stocks retreated in the week ending Oct. 8, extending losses for the third straight week. Some of the selling in the space was due to money moving out of defensive...

Via Benzinga

Mid-Afternoon Market Update: Dow Surges 80 Points; ChemoCentryx Shares Spike Higher ↗

October 08, 2021

Toward the end of trading Friday, the Dow traded up 0.24% to 34,835.06 while the NASDAQ fell 0.13% to 14,635.04. The S&P also rose, gaining 0.13% to 4,405.69. The U.S. has the...

Via Benzinga

Topics Stocks

ChemoCentryx, Allogene Show the Risks and Rewards of Nasdaq Biotech Stocks ↗

October 08, 2021

The broader market was mixed on Friday.

Via The Motley Fool

Topics Stocks

Why Allogene Therapeutics Stock Is Getting Hammered Today ↗

October 08, 2021

A possible safety issue is crushing the biotech's shares today.

Via The Motley Fool

12 Health Care Stocks Moving In Friday's Intraday Session ↗

October 08, 2021

Gainers ChemoCentryx (NASDAQ:CCXI) stock increased by 70.43% to $33.41 during Friday's regular session. As of 12:30 EST, this security is trading at a volume of 74.6...

Via Benzinga

Mid-Day Market Update: Crude Oil Rises 2%; Allogene Therapeutics Shares Plunge ↗

October 08, 2021

Midway through trading Friday, the Dow traded down 0.06% to 34,734.52 while the NASDAQ fell 0.25% to 14,617.60. The S&P also fell, dropping 0.08% to 4,396.09. The U.S. has the...

Via Benzinga

Topics Stocks

Where Allogene Therapeutics Stands With Analysts ↗

October 08, 2021

Analysts have provided the following ratings for Allogene Therapeutics (NASDAQ:

Via Benzinga

28 Stocks Moving In Friday's Mid-Day Session ↗

October 08, 2021

Gainers ChemoCentryx, Inc. (NASDAQ: CCXI) shares climbed 60.8% to $31.51. The FDA approved ChemoCentryx’s Tavneos (avacopan) as an adjunctive treatment for anti-neutrophil...

Via Benzinga

Mid-Morning Market Update: Markets Edge Higher; US Economy Adds 194,000 Jobs In September ↗

October 08, 2021

Following the market opening Friday, the Dow traded up 0.12% to 34,796.95 while the NASDAQ rose 0.09% to 14,667.44. The S&P also rose, gaining 0.16% to 4,406.93. The U.S. has...

Via Benzinga

Topics Economy Stocks

Benzinga's Top Ratings Upgrades, Downgrades For October 8, 2021 ↗

October 08, 2021

Upgrades UBS upgraded the previous rating for Northern Trust Corp (NASDAQ:

Via Benzinga

10 Biggest Price Target Changes For Friday ↗

October 08, 2021

Barclays cut the price target on Constellation Brands, Inc. (NYSE:

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

October 08, 2021

Gainers ChemoCentryx (NASDAQ:CCXI) shares rose 77.65% to $34.82 during Friday's pre-market session. The company's market cap stands at $2.4 billion. eFFECTOR...

Via Benzinga

18 Stocks Moving in Friday's Pre-Market Session ↗

October 08, 2021

Gainers eFFECTOR Therapeutics, Inc. (NASDAQ: EFTR) rose 25.5% to $14.41 in pre-market trading after the company, in collaboration with investigators at Baylor College of Medicine...

Via Benzinga

Allogene Craters To 52-Week Low On FDA Clinical Hold Of CAR-T Trials, Drags Peers As Well ↗

October 08, 2021

The FDA has sent shockwaves through the off-the-shelf CAR-T space after it slapped a clinical hold on all of the Allogene Therapeutics Inc (NASDAQ: ALLO)...

Via Benzinga

The Daily Biotech Pulse: Allogene Sinks On FDA Clinical Hold, Takeda Gets Adcom Backing, Quidel Reports Q3 COVID Revenues, IPOs ↗

October 08, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 7) Alkermes plc (NASDAQ: ALKS)...

Via Benzinga

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Sections

News
Sports
Local Events
Obituaries
Multimedia
Online Features

Services

Contact Us
Subscription Services
Submission Forms
Classifieds
Place an Ad
Promote Your Event
Email Alerts
Search
Weather

Contact Information

MammothTimes.com
645 Old Mammoth Road, Suite A
Mammoth Lakes, CA 93546
Phone: 760-934-3929

Advertising

Retail Sales: egalanski@mammothtimes.com
Classified Sales: sales@mammothtimes.com

Facebook

Browser Compatibility

Your browser is out of date and potentially vulnerable to security risks.
We recommend switching to one of the following browsers:

Microsoft Edge Google Chrome Firefox

Mammoth Lakes, CA (93546)

Today

Tonight

Allogene Therapeutics, Inc. - Common Stock (NQ:ALLO)

All News about Allogene Therapeutics, Inc. - Common Stock

Sections

Services

Contact Information